0001752724-22-269401.txt : 20221128 0001752724-22-269401.hdr.sgml : 20221128 20221128113241 ACCESSION NUMBER: 0001752724-22-269401 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221128 DATE AS OF CHANGE: 20221128 PERIOD START: 20221231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSAMERICA SERIES TRUST CENTRAL INDEX KEY: 0000778207 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-04419 FILM NUMBER: 221422603 BUSINESS ADDRESS: STREET 1: 1801 CALIFORNIA STREET STREET 2: SUITE 5200 CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 720-482-8836 MAIL ADDRESS: STREET 1: 1801 CALIFORNIA STREET STREET 2: SUITE 5200 CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: AEGON/TRANSAMERICA SERIES TRUST DATE OF NAME CHANGE: 20050511 FORMER COMPANY: FORMER CONFORMED NAME: AEGON/TRANSAMERICA SERIES FUND INC DATE OF NAME CHANGE: 20010501 FORMER COMPANY: FORMER CONFORMED NAME: WRL SERIES FUND INC DATE OF NAME CHANGE: 19920703 0000778207 S000007912 Transamerica Morgan Stanley Capital Growth VP C000021469 Initial C000021470 Service NPORT-P 1 primary_doc.xml NPORT-P false 0000778207 XXXXXXXX S000007912 C000021469 C000021470 TRANSAMERICA SERIES TRUST 811-04419 0000778207 5493000QR1WGXIM5V222 1801 CALIFORNIA STREET SUITE 5200 DENVER 80202 720-493-4256 Transamerica Morgan Stanley Capital Growth VP S000007912 549300WQP4ZZ4SI8CF52 2022-12-31 2022-09-30 N 1071371053.91 168313840.64 903057213.27 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 2940.23000000 UST Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 Option 000000000 643088655.88000000 OU Notional Amount USD 3293900.10000000 0.364749879808 N/A DFE US N 2 Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 Call Purchased Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 FX Contract N/A 1.00000000 NC USD 3293900.10000000 0.36000000 DFE US 4675254528.00000000 CNY 643088655.90000000 USD 2022-11-10 1.00000000 7.27000000 USD 2022-11-10 XXXX 206679.05000000 N N N 10X Genomics Inc 5493003Z6741WNLG7H43 10X Genomics, Inc. 88025U109 371999.00000000 NS USD 10594531.52000000 1.173184972592 Long EC CORP US N 1 N N N Alnylam Pharmaceuticals Inc 529900S3ZI14OWRJII50 Alnylam Pharmaceuticals, Inc. 02043Q107 16701.00000000 NS USD 3342872.16000000 0.370172798675 Long EC CORP US N 1 N N N JPMorgan Securities LLC ZBUT11V806EZRVTWT807 Option 000000000 205423910.29000000 OU Notional Amount USD 1896884.39000000 0.210051407831 N/A DFE US N 2 JPMorgan Securities LLC ZBUT11V806EZRVTWT807 Call Purchased JPMorgan Securities LLC ZBUT11V806EZRVTWT807 JPMorgan Securities LLC ZBUT11V806EZRVTWT807 FX Contract N/A 1.00000000 NC USD 1896884.39000000 0.21000000 DFE US 1546842044.00000000 CNY 205423910.30000000 USD 2023-07-21 1.00000000 7.53000000 USD 2023-07-21 XXXX 876954.68000000 N N N agilon health Inc N/A agilon health, Inc. 00857U107 1262035.00000000 NS USD 29556859.70000000 3.272977532948 Long EC CORP US N 1 N N Cloudflare Inc 5493007DY18BGNLDWU14 Cloudflare, Inc. 18915M107 1033361.00000000 NS USD 57155196.91000000 6.329078165827 Long EC CORP US N 1 N N N Uber Technologies Inc 549300B2FTG34FILDR98 Uber Technologies, Inc. 90353T100 2064141.00000000 NS USD 54699736.50000000 6.057172867478 Long EC CORP US N 1 N N N State Street Global Advisors 5493008BJIBKQ5KTIF74 State Street Navigator Securities Lending Government Money Market Portfolio 857492706 45092217.25000000 NS USD 45092217.25000000 4.993284654326 Long STIV RF US N 1 N N Sea Ltd 529900OM6JLLW44YKI15 Sea Ltd. 81141R100 177587.00000000 NS USD 9953751.35000000 1.102228209213 Long EC CORP KY N 1 N N Aurora Innovation Inc N/A Aurora Innovation, Inc. 051774107 900563.00000000 NS USD 1990244.23000000 0.220389605526 Long EC CORP US N 1 N N Bill.com Holdings Inc 549300IBF9VZZIGOZW63 Bill.com Holdings, Inc. 090043100 324652.00000000 NS USD 42974185.24000000 4.758744474714 Long EC CORP US N 1 N N N Carvana Co 5493003WEAK2PJ5WS063 Carvana Co. 146869102 300723.00000000 NS USD 6104676.90000000 0.676001122663 Long EC CORP US N 1 N N ZoomInfo Technologies Inc N/A ZoomInfo Technologies, Inc. 98980F104 587904.00000000 NS USD 24492080.64000000 2.712129450947 Long EC CORP US N 1 N N N Wayfair Inc 54930027N9ZAVYFDHK53 Wayfair, Inc. 94419L101 226708.00000000 NS USD 7379345.40000000 0.817151481829 Long EC CORP US N 1 N N Intellia Therapeutics Inc 5493002T5BCPE5DZC723 Intellia Therapeutics, Inc. 45826J105 24492.00000000 NS USD 1370572.32000000 0.151770264370 Long EC CORP US N 1 N N N ASML Holding NV 724500Y6DUVHQD6OXN27 ASML Holding NV 000000000 53081.00000000 NS USD 22047193.35000000 2.441394966567 Long EC CORP NL Y 1 N N N Block Inc 549300OHIIUWSTIZME52 Block, Inc. 852234103 216822.00000000 NS USD 11923041.78000000 1.320297496636 Long EC CORP US N 1 N N N Veeva Systems Inc 549300YZEXPDB92M2F02 Veeva Systems, Inc. 922475108 57631.00000000 NS USD 9502199.28000000 1.052225610998 Long EC CORP US N 1 N N N Trade Desk Inc/The 549300GXPD31VT3E0P46 Trade Desk, Inc. 88339J105 1092395.00000000 NS USD 65270601.25000000 7.227737101357 Long EC CORP US N 1 N N N Moderna Inc 549300EI6OKH5K5Q2G38 Moderna, Inc. 60770K107 18227.00000000 NS USD 2155342.75000000 0.238671782731 Long EC CORP US N 1 N N N Coupang Inc 549300XR4L1D80AK4W76 Coupang, Inc. 22266T109 1373248.00000000 NS USD 22892044.16000000 2.534949483112 Long EC CORP US N 1 N N N Adyen NV 724500973ODKK3IFQ447 Adyen NV 000000000 22273.00000000 NS 27778024.47000000 3.075998293553 Long EC CORP NL Y 2 N N N Illumina Inc SQ95QG8SR5Q56LSNF682 Illumina, Inc. 452327109 49999.00000000 NS USD 9539309.21000000 1.056334977432 Long EC CORP US N 1 N N N Doximity Inc N/A Doximity, Inc. 26622P107 418497.00000000 NS USD 12646979.34000000 1.400462689867 Long EC CORP US N 1 N N MongoDB Inc 549300TPTG69WKWE1Z37 MongoDB, Inc. 60937P106 63613.00000000 NS USD 12630997.28000000 1.398692917169 Long EC CORP US N 1 N N N Guardant Health Inc 254900M8C3E5VC8BR186 Guardant Health, Inc. 40131M109 195859.00000000 NS USD 10543089.97000000 1.167488594861 Long EC CORP US N 1 N N Ginkgo Bioworks Holdings Inc N/A Ginkgo Bioworks Holdings, Inc. 37611X100 1643807.00000000 NS USD 5128677.84000000 0.567923910538 Long EC CORP US N 1 N N DoorDash Inc 549300NUQ43FGGSK5051 DoorDash, Inc. 25809K105 713872.00000000 NS USD 35300970.40000000 3.909051373630 Long EC CORP US N 1 N N N Fixed Income Clearing Corp 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 34838017.37000000 PA USD 34838017.37000000 3.857786290621 Long RA CORP US N 2 Repurchase N 1.10000000 2022-10-03 30169000.00000000 USD 35534859.55000000 USD UST N N N Affirm Holdings Inc N/A Affirm Holdings, Inc. 00827B106 434960.00000000 NS USD 8159849.60000000 0.903580579402 Long EC CORP US N 1 N N Dexcom Inc 549300YSK3QDSFR5EU59 Dexcom, Inc. 252131107 68024.00000000 NS USD 5478652.96000000 0.606678389751 Long EC CORP US N 1 N N N Snowflake Inc 254900CJNSY1K7T53Z16 Snowflake, Inc. 833445109 446231.00000000 NS USD 75841420.76000000 8.398296325586 Long EC CORP US N 1 N N N Gitlab Inc N/A Gitlab, Inc. 37637K108 276621.00000000 NS USD 14168527.62000000 1.568951270395 Long EC CORP US N 1 N N ProKidney Corp N/A ProKidney Corp. 000000000 83644.00000000 NS USD 753632.44000000 0.083453454435 Long EC CORP KY N 1 N N Datadog Inc 549300F6JNO0KRPO1K63 Datadog, Inc. 23804L103 516034.00000000 NS USD 45813498.52000000 5.073155703403 Long EC CORP US N 1 N N N Global-e Online Ltd N/A Global-e Online Ltd. 000000000 156993.00000000 NS USD 4201132.68000000 0.465212238855 Long EC CORP IL N 1 N N N Shopify Inc 549300HGQ43STJLLP808 Shopify, Inc. 82509L107 1315703.00000000 NS USD 35445038.82000000 3.925004783656 Long EC CORP CA N 1 N N N Peloton Interactive Inc 5493002YS021166W0339 Peloton Interactive, Inc. 70614W100 496208.00000000 NS USD 3438721.44000000 0.380786664396 Long EC CORP US N 1 N N Unity Software Inc 549300D1ESJMGNQNG432 Unity Software, Inc. 91332U101 279952.00000000 NS USD 8919270.72000000 0.987675043057 Long EC CORP US N 1 N N ROBLOX Corp N/A ROBLOX Corp. 771049103 1266435.00000000 NS USD 45389030.40000000 5.026152245176 Long EC CORP US N 1 N N Standard Chartered Bank RILFO74KP1CM8P6PCT96 Option 000000000 233319924.92000000 OU Notional Amount USD 2148409.87000000 0.237904070576 N/A DFE US N 2 Standard Chartered Bank RILFO74KP1CM8P6PCT96 Call Purchased Standard Chartered Bank RILFO74KP1CM8P6PCT96 Standard Chartered Bank RILFO74KP1CM8P6PCT96 FX Contract N/A 1.00000000 NC USD 2148409.87000000 0.24000000 DFE US 1765998512.00000000 CNY 233319924.90000000 USD 2023-08-23 1.00000000 7.56900000 USD 2023-08-23 XXXX 1106869.73000000 N N N Chewy Inc 254900NPQSTG9I422879 Chewy, Inc. 16679L109 578033.00000000 NS USD 17757173.76000000 1.966339839720 Long EC CORP US N 1 N N Rivian Automotive Inc N/A Rivian Automotive, Inc. 76954A103 145115.00000000 NS USD 4775734.65000000 0.528840762226 Long EC CORP US N 1 N N MercadoLibre Inc 549300DKPDN9M5S8GB14 MercadoLibre, Inc. 58733R102 27105.00000000 NS USD 22436976.90000000 2.484557630491 Long EC CORP US N 1 N N N Royalty Pharma PLC 549300FGFN7VOK8BZR03 Royalty Pharma PLC 000000000 1458649.00000000 NS USD 58608516.82000000 6.490011480864 Long EC CORP GB N 1 N N N Coinbase Global Inc 5493004G3J2SC154DU06 Coinbase Global, Inc. 19260Q107 129590.00000000 NS USD 8357259.10000000 0.925440711529 Long EC CORP US N 1 N N N Grab Holdings Ltd 549300N4VQX83VPJF439 Grab Holdings Ltd. 000000000 4563533.00000000 NS USD 12002091.79000000 1.329051095947 Long EC CORP KY N 1 N N Upstart Holdings Inc 549300WNB47JRNENIC75 Upstart Holdings, Inc. 91680M107 77541.00000000 NS USD 1612077.39000000 0.178513317463 Long EC CORP US N 1 N N 2022-10-31 TRANSAMERICA SERIES TRUST Vincent Toner Vincent Toner Treasurer XXXX NPORT-EX 2 NPORT_IBPO_49623412_0922.htm HTML

Transamerica Morgan Stanley Capital Growth VP

 

SCHEDULE OF INVESTMENTS

At September 30, 2022

(unaudited)

 

     Shares      Value  
COMMON STOCKS - 96.4%  
Automobiles - 0.5%  

Rivian Automotive, Inc., Class A (A) (B)

     145,115        $  4,775,735  
     

 

 

 
Biotechnology - 1.4%  

Alnylam Pharmaceuticals, Inc. (A)

     16,701        3,342,872  

Ginkgo Bioworks Holdings, Inc. (A) (B)

     1,643,807        5,128,678  

Intellia Therapeutics, Inc. (A)

     24,492        1,370,572  

Moderna, Inc. (A)

     18,227        2,155,343  

ProKidney Corp. (A) (B)

     84,430        760,714  
     

 

 

 
        12,758,179  
     

 

 

 
Capital Markets - 0.9%  

Coinbase Global, Inc., Class A (A)

     129,590        8,357,259  
     

 

 

 
Commercial Services & Supplies - 0.2%  

Aurora Innovation, Inc. (A) (B)

     900,563        1,990,244  
     

 

 

 
Consumer Finance - 0.2%  

Upstart Holdings, Inc. (A) (B)

     77,541        1,612,077  
     

 

 

 
Entertainment - 6.1%  

ROBLOX Corp., Class A (A) (B)

     1,266,435        45,389,031  

Sea Ltd., ADR (A) (B)

     177,587        9,953,751  
     

 

 

 
        55,342,782  
     

 

 

 
Health Care Equipment & Supplies - 0.6%  

Dexcom, Inc. (A)

     68,024        5,478,653  
     

 

 

 
Health Care Providers & Services - 4.4%  

agilon health, Inc. (A) (B)

     1,262,035        29,556,860  

Guardant Health, Inc. (A) (B)

     195,859        10,543,090  
     

 

 

 
        40,099,950  
     

 

 

 
Health Care Technology - 2.5%  

Doximity, Inc., Class A (A) (B)

     418,497        12,646,980  

Veeva Systems, Inc., Class A (A)

     57,631        9,502,199  
     

 

 

 
        22,149,179  
     

 

 

 
Interactive Media & Services - 2.7%  

ZoomInfo Technologies, Inc. (A)

     587,904        24,492,081  
     

 

 

 
Internet & Direct Marketing Retail - 13.5%  

Chewy, Inc., Class A (A) (B)

     578,033        17,757,174  

Coupang, Inc. (A)

     1,373,248        22,892,044  

DoorDash, Inc., Class A (A)

     713,872        35,300,970  

Global-e Online Ltd. (A)

     159,489        4,267,926  

Grab Holdings Ltd., Class A (A) (B)

     4,563,533        12,002,092  

MercadoLibre, Inc. (A)

     27,105        22,436,977  

Wayfair, Inc., Class A (A) (B)

     226,708        7,379,345  
     

 

 

 
        122,036,528  
     

 

 

 
IT Services - 25.4%  

Adyen NV (A) (C)

     22,273        27,778,024  

Affirm Holdings, Inc. (A) (B)

     434,960        8,159,850  

Block, Inc. (A)

     216,822        11,923,042  

Cloudflare, Inc., Class A (A)

     1,033,361        57,155,197  

MongoDB, Inc. (A)

     63,613        12,630,997  

Shopify, Inc., Class A (A)

     1,315,703        35,445,039  

Snowflake, Inc., Class A (A)

     446,231        75,841,421  
     

 

 

 
        228,933,570  
     

 

 

 
Leisure Products - 0.4%  

Peloton Interactive, Inc., Class A (A) (B)

     496,208        3,438,721  
     

 

 

 
     Shares      Value  
COMMON STOCKS (continued)  
Life Sciences Tools & Services - 2.2%  

10X Genomics, Inc., Class A (A)

     371,999        $  10,594,532  

Illumina, Inc. (A)

     49,999        9,539,309  
     

 

 

 
        20,133,841  
     

 

 

 
Pharmaceuticals - 6.5%  

Royalty Pharma PLC, Class A

     1,458,649        58,608,517  
     

 

 

 
Road & Rail - 6.1%  

Uber Technologies, Inc. (A)

     2,064,141        54,699,736  
     

 

 

 
Semiconductors & Semiconductor Equipment - 2.5%  

ASML Holding NV

     53,081        22,047,193  
     

 

 

 
Software - 19.6%  

Bill.com Holdings, Inc. (A)

     324,652        42,974,185  

Datadog, Inc., Class A (A)

     516,034        45,813,498  

Gitlab, Inc., Class A (A) (B)

     276,621        14,168,528  

Trade Desk, Inc., Class A (A)

     1,092,395        65,270,601  

Unity Software, Inc. (A) (B)

     279,952        8,919,271  
     

 

 

 
        177,146,083  
     

 

 

 
Specialty Retail - 0.7%  

Carvana Co. (A) (B)

     300,723        6,104,677  
     

 

 

 

Total Common Stocks
(Cost $1,486,657,799)

 

     870,205,005  
  

 

 

 
OTHER INVESTMENT COMPANY - 4.9%  
Securities Lending Collateral - 4.9%  

State Street Navigator Securities Lending Trust - Government Money Market Portfolio, 3.03% (D)

     44,476,781        44,476,781  
     

 

 

 

Total Other Investment Company
(Cost $44,476,781)

 

     44,476,781  
  

 

 

 
     Principal      Value  
REPURCHASE AGREEMENT - 3.9%  

Fixed Income Clearing Corp., 1.10% (D), dated 09/30/2022, to be repurchased at $34,841,211 on 10/03/2022. Collateralized by a U.S. Government Obligation, 0.63%, due 04/15/2023, and with a value of $35,534,860.

     $  34,838,017        34,838,017  
     

 

 

 

Total Repurchase Agreement
(Cost $34,838,017)

 

     34,838,017  
  

 

 

 

Total Investments Excluding Options Purchased
(Cost $1,565,972,597)

 

     949,519,803  

Total Options Purchased - 0.8%
(Cost $5,148,691)

 

     7,339,194  
  

 

 

 

Total Investments
(Cost $1,571,121,288)

 

     956,858,997  

Net Other Assets (Liabilities) - (6.0)%

        (54,035,983
     

 

 

 

Net Assets - 100.0%

        $  902,823,014  
     

 

 

 
 

 

Transamerica Series Trust

    Page    1         


Transamerica Morgan Stanley Capital Growth VP

 

SCHEDULE OF INVESTMENTS (continued)

At September 30, 2022

(unaudited)

 

OVER-THE-COUNTER FOREIGN EXCHANGE OPTIONS PURCHASED:

 

 

Description

   Counterparty      Exercise
Price
     Expiration
Date
     Notional Amount/
Number of Contracts
     Premiums
Paid
     Value  

Put - USD vs. CNH

     GSI        USD        7.27        11/10/2022        USD        643,088,656      $ 3,087,221      $ 3,293,900  

Put - USD vs. CNH

     JPM        USD        7.53        07/21/2023        USD        205,423,910        1,019,930        1,896,884  

Put - USD vs. CNH

     SCB        USD        7.57        08/23/2023        USD        233,319,925        1,041,540        2,148,410  
                    

 

 

    

 

 

 

Total

                     $     5,148,691      $     7,339,194  
                    

 

 

    

 

 

 

INVESTMENT VALUATION:

 

Valuation Inputs (E)

 

     Level 1 -
Unadjusted
Quoted

Prices
     Level 2 -
Other
Significant
Observable
Inputs
     Level 3 -
Significant
Unobservable
Inputs
     Value  

ASSETS

 

Investments

 

Common Stocks

   $ 842,426,981      $ 27,778,024      $ —        $ 870,205,005  

Other Investment Company

     44,476,781        —          —          44,476,781  

Repurchase Agreement

     —          34,838,017        —          34,838,017  

Over-the-Counter Foreign Exchange Options Purchased

     —          7,339,194        —          7,339,194  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Investments

   $     886,903,762      $     69,955,235      $     —        $     956,858,997  
  

 

 

    

 

 

    

 

 

    

 

 

 

FOOTNOTES TO SCHEDULE OF INVESTMENTS:

 

(A)      Non-income producing securities.
(B)      All or a portion of the securities are on loan. The total value of all securities on loan is $110,967,826, collateralized by cash collateral of $44,476,781 and non-cash collateral, such as U.S. government securities and irrevocable letters of credit, of $69,539,921. The amount of securities on loan indicated may not correspond with the securities on loan identified because securities with pending sales are in the process of recall from the brokers.
(C)      Security is exempt from registration pursuant to Rule 144A of the Securities Act of 1933. Security may be resold as transactions exempt from registration, normally to qualified institutional buyers. At September 30, 2022, the value of the 144A security is $27,778,024, representing 3.1% of the Portfolio’s net assets.
(D)      Rates disclosed reflect the yields at September 30, 2022.
(E)      There were no transfers in or out of Level 3 during the period ended September 30, 2022. Please reference the Investment Valuation section of the Notes to Schedule of Investments for more information regarding investment valuation and pricing inputs.

CURRENCY ABBREVIATIONS:

 

CNH

   Chinese Yuan Renminbi (offshore)

USD

   United States Dollar

COUNTERPARTY ABBREVIATIONS:

 

GSI

   Goldman Sachs International

JPM

   JPMorgan Chase Bank, N.A.

SCB

   Standard Chartered Bank

PORTFOLIO ABBREVIATION:

 

ADR

   American Depositary Receipt

 

Transamerica Series Trust

    Page    2         


Transamerica Morgan Stanley Capital Growth VP

 

NOTES TO SCHEDULE OF INVESTMENTS

At September 30, 2022

(unaudited)

 

INVESTMENT VALUATION

Transamerica Morgan Stanley Capital Growth VP (the “Portfolio”) is a series of the Transamerica Series Trust.

Pursuant to the requirements set forth in SEC Rule 2a-5, effective September 8, 2022, the Board has designated the Portfolio’s investment manager, Transamerica Asset Management, Inc. (“TAM”), to perform fair value determination on behalf of the Portfolio, subject to the oversight of the Board. TAM is subject to Board oversight and certain reporting and other requirements intended to provide the Board the information needed to oversee TAM’s fair value determinations. All investments in securities are recorded at their estimated fair value. TAM values the Portfolio’s investments at the official close of the New York Stock Exchange (“NYSE”) each day the NYSE is open for business.

TAM utilizes various methods to measure the fair value of its investments on a recurring basis. Generally Accepted Accounting Principles in the United States of America establishes a hierarchy that prioritizes inputs to valuation methods. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The three levels (“Levels”) of inputs of the fair value hierarchy are defined as follows:

Level 1 — Unadjusted quoted prices in active markets for identical securities.

Level 2 — Inputs, other than quoted prices included in Level 1, which are observable, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates, and similar data.

Level 3 — Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available, which may include TAM’s own assumptions used in determining the fair value of the Portfolio’s investments and derivative instruments.

The inputs used to measure fair value may fall into different Levels of the fair value hierarchy. In such cases, for disclosure purposes, the Level in the fair value hierarchy that is assigned to the fair value measurement of a security is determined based on the lowest Level input that is significant to the fair value measurement in its entirety. Certain investments that are measured at fair value using Net Asset Value (“NAV”) per share, or its equivalent, using the “practical expedient” have not been classified in the fair value Levels. The hierarchy classification of inputs used to value the Portfolio’s investments at September 30, 2022, is disclosed within the Investment Valuation section of the Schedule of Investments.

The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, but not limited to, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is generally greatest for instruments categorized in Level 3. Due to the inherent uncertainty of valuation, the determination of values may differ significantly from values that would have been realized had a ready market for investments existed, and the differences could be material.

Fair value measurements: Descriptions of the valuation techniques applied to the Portfolio’s significant categories of assets and liabilities measured at fair value on a recurring basis are as follows:

Equity securities: Securities are stated at the last reported sales price or closing price on the day of valuation taken from the primary exchange where the security is principally traded. To the extent these securities are actively traded and valuation adjustments are not applied, they are categorized in Level 1 of the fair value hierarchy. Equities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 or Level 3 if inputs are unobservable.

Foreign equity securities: Securities in which the primary trading market closes at the same time or after the NYSE, are valued based on quotations from the primary market in which they are traded and are categorized in Level 1. Because many foreign securities markets and exchanges close prior to the close of the NYSE, closing prices for foreign securities in those markets or on those exchanges do not reflect the events that occur after that close. Certain foreign securities may be fair valued using a pricing service that considers the correlation of the trading patterns of the foreign security to the intraday trading in the U.S. markets for investments such as American Depositary Receipts, financial futures, or ETFs and the movement of certain indices of securities based on a statistical analysis of their historical relationship; such valuations generally are categorized in Level 2.

Securities lending collateral: Securities lending collateral is invested in a money market fund which is valued at the actively traded NAV and no valuation adjustments are applied. Securities lending collateral is categorized in Level 1 of the fair value hierarchy.

Repurchase agreements: Repurchase agreements are valued at cost, which approximates fair value. To the extent the inputs are observable and timely, the values are generally categorized in Level 2 of the fair value hierarchy.

 

Transamerica Series Trust

    Page    3         


Transamerica Morgan Stanley Capital Growth VP

 

NOTES TO SCHEDULE OF INVESTMENTS (continued)

At September 30, 2022

(unaudited)

 

Derivative instruments: Centrally cleared or listed derivatives that are actively traded are valued based on quoted prices from the exchange and are categorized in Level 1 of the fair value hierarchy. Over-the-counter (“OTC”) derivative contracts include forward, swap, swaption, and option contracts related to interest rates, foreign currencies, credit standing of reference entities, equity prices, or commodity prices. Depending on the product and the terms of the transaction, the fair value of the OTC derivative products are modeled taking into account the counterparties’ creditworthiness and using a series of techniques, including simulation models. Many pricing models do not entail material subjectivity because the methodologies employed do not necessitate significant judgments and the pricing inputs are observed from actively quoted markets, as is the case of interest rate swap and option contracts. The majority of OTC derivative products valued by the Portfolio using pricing models fall into this category and are categorized within Level 2 of the fair value hierarchy or Level 3 if inputs are unobservable.

 

Transamerica Series Trust

    Page    4